7 Best Marijuana Stocks and ETFs to Buy in 2026
In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.
TFSA investors: An undervalued cannabis stock you can buy for $500 right now
Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December 2025. The post TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now appeared first on The Motley Fool Canada.
This cannabis stock got destroyed in 2025. Can Trump make 2026 a different story?
Cannabis stocks are once again in the spotlight for investors, with a range of companies in this sector seeing big increases over the past week. The list of cannabis companies shows extremely diverse …
This Stock Has Almost Tripled in 6 Months. Here’s What Investors Need to Watch Next
Now, it’s worth noting Stock Advisor’s total average return is 975 % — a market-crushing outperformance compared to 193% for the S&P 500. Don’t miss the latest top 10 list, available with Stock …
Cannabis use among seniors is up 46% as Trump moves to reclassify marijuana. Here’s what it could mean for pot stocks
This comes at a time when cannabis use among boomers is, well, booming. The number of Americans aged 65+ using cannabis for medical purposes rose from 4.8% in 2021 to 7% in 2023, …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Fight the Urge to Sell: 3 Stocks With Terrible Charts That Still Look Like Buying Opportunities If You’re Patient Enough
I recently saw a social media post which stood out to me. This post was a long-term chart going back about 50 years, highlighting all the downturns over this time frame, and all the reasons investors …
Why I Am Upgrading SNDL
Cannabis stocks heated up recently due to the potential rescheduling news. They had started heating up in Q3, ahead of the 8/11 news conference that President Trump held. At that time, thought that …
Three pot stocks analysts love right now
Analysts covering the sector have turned more constructive on cannabis stocks, citing improved regulatory clarity and potential financial benefits for operators …
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations
Federal rescheduling efforts, coupled with improved corporate balance sheets, may finally unlock long-awaited profitability for cannabis-sector leaders.
Cannabis Stocks Up for Reversal: Pipedreams or Opportunity?
Cannabis stocks are set up to complete market reversals that relaxed federal regulations could trigger. Rescheduling isn’t legalization, but it’s good enough.
Cannabis stocks soar 18% on promising Trump policy move
Cannabis companies experienced a remarkable Thursday as investors responded enthusiastically to reports that President Donald Trump plans to sign an executive order addressing federal marijuana …
Why Trulieve Cannabis Skyrocketed 14.1% Today
President Trump confirmed his administration is considering reclassifying marijuana to Schedule III. Trulieve stands out as one of the few companies operating with significant pre-tax earnings. The …
Trump’s giving cannabis stocks a lift—and the optimism may be justified
After many false starts, investors are once again betting that marijuana businesses are close to seeing federal restrictions ease.
As Trump Considers Signing a Cannabis Executive Order, Should You Buy the Dip in Tilray Stock?
Canadian cannabis stocks, including Tilray (TLRY), surged following reports that President Donald Trump could sign an executive order as soon as Monday reclassifying marijuana from a Schedule I drug like heroin to the less-restrictive Schedule III category,
Recent Comments